shortagewatch

Home / Companies / Neuraxpharm

Company family · HQ DE

Neuraxpharm: medicine shortages

private

As of 2 Nov 2026, 75 Neuraxpharm products have a reported shortage across 7 countries, covering 19 medicines.

Products short75rank #27 of 464
Medicines19active ingredients
Countries7/16
New in 90 days17+9 vs market pace
Typical duration21 monthsmedian so far
Manufacturing81%demand-driven 2%

Where

Germany26Italy5Spain19Austria9Belgium1Czechia13Sweden2

Which therapeutic classes

Nervous system72Cardiovascular system2Anti-infectives1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
NeuraxpharmNeuraxpharm: Manufacturing problem 44 (62%)62%Neuraxpharm: Increased demand 1 (1%)Neuraxpharm: Commercial decision or withdrawal 2 (3%)Neuraxpharm: Regulatory or licensing 3 (4%)4%Neuraxpharm: Not stated 21 (30%)30%All companiesAll companies: Manufacturing problem 4,896 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,220 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes
DateCountryMedicineChange
2 NovESQuetiapine
PSICOTRIC PROLONG 200 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 60 comprimidos		return date missed (was 1 Nov)
1 NovDEFlupentixol
Flupentixol-neuraxpharm 40 mg/ml		resolved
1 NovDESultiame
Sultiam-neuraxpharm 50 mg Filmtabletten		resolved

Open shortages over time

4344464731 Oct2026-10-31: 461 Nov2026-11-01: 442 Nov2026-11-02: 44

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

025710Dec: 5Jan ’25: 5Feb: 5FebMar: 1Apr: 0May: 0MayJun: 1Jul: 0Aug: 0AugSep: 2Oct: 1Nov: 1NovDec: 3Jan ’26: 0Feb: 1FebMar: 1Apr: 0May: 2MayJun: 1Jul: 1Aug: 6AugSep: 4Oct: 6Nov: 1Nov

Against its peers

Viatris995Teva903Sandoz603Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Neuraxpharm75

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 603 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 150 / 73Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Neuraxpharm: 75 / 19Neuraxpharm

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Quetiapine379 Jul 2024Manufacturing problem12/16
Galantamine72 Jan 2025Manufacturing problem7/16
Memantine34 Dec 2024Manufacturing problem8/16
Midazolam328 Sep 2026Manufacturing problem7/16
Potassium Clorazepate312 Nov 2024Not stated2/16
Ropinirole315 Aug 2024Manufacturing problem8/16
Chlorpromazine24 Aug 2016Not stated3/16
Nortriptyline21 Sep 2025Manufacturing problem2/16
Paliperidone229 Jun 2026Not stated11/16
Pregabalin220 Oct 2026Commercial decision or withdrawal11/16
Trimipramine25 May 2016Regulatory or licensing2/16
Zonisamide220 Aug 2026Not stated4/16
Guanfacine119 Oct 2026Not stated3/16
Levomepromazine125 Sep 2026Increased demand2/16
Methylphenidate12 Nov 2026Not stated9/16
Moxifloxacin18 Dec 2025Not stated8/16
Paracetamol112 Aug 2026Not stated10/16
Pentoxifylline115 Aug 2026Regulatory or licensing5/16
Sulpiride120 Dec 2026Manufacturing problem1/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.